Daxiang Biomedical

Daxiang Biomedical is a Shenzhen-based biotechnology company specializing in the development of organ-on-a-chip technology to revolutionize drug discovery and precision medicine. The company integrates microfluidics, tissue engineering, and biomaterials to create high-fidelity human organ models that better predict clinical outcomes compared to traditional animal models. Their platform is designed to accelerate the screening of drug candidates and reduce the high failure rates associated with late-stage clinical trials. Daxiang Biomedical focuses on therapeutic areas including oncology and metabolic diseases, leveraging their proprietary technology to identify novel targets and optimize lead compounds. By providing more accurate human physiological data early in the development process, the company aims to lower the cost and time required to bring new therapies to market.